Continuous Quality Improvement - NAPLEX

Reckless behavior (conscious disregard of substantial risk). In just culture, reckless behavior warrants accountability due to its intentional risk to patient safety.

FMEA. FMEA is ideal for preemptively assessing risks in new processes to ensure safe implementation.

Pareto chart. Pareto charts rank issues by impact, enabling targeted interventions on the most frequent problems.

Ensure patient safety first, then disclose, document, and report per policy. Prioritizing safety and transparency after errors aligns with ethical standards and legal requirements in pharmacy.

Process measure. Tracking verification time evaluates the efficiency of workflow steps in pharmacy operations.

Cause-and-effect (fishbone/Ishikawa) diagram. Cause-and-effect diagrams systematically categorize potential root causes to facilitate problem-solving in CQI.

Visually depict workflow steps to identify gaps, delays, and failure points. Process maps illustrate sequential steps, revealing inefficiencies and opportunities for optimization in workflows.

Tall man lettering with physical separation and barcode verification. These strategies minimize confusion by enhancing visual distinction and technological checks in drug handling.

Ongoing, data-driven process to improve safety, quality, and outcomes. This definition emphasizes CQI's systematic, iterative nature using data to enhance pharmacy practices and patient care.

Reduce patient harm by improving processes and preventing errors. CQI targets systemic enhancements in medication processes to minimize risks and optimize health results.

Process: how care is done; Outcome: result of care on patient/system. Process measures assess operational efficiency, while outcome measures evaluate the impact on patient health or system performance.

Resources and settings that support care (staffing, equipment, policies). Structure measures examine foundational elements that enable effective healthcare delivery and quality.

Prospectively identifies process failure points and prioritizes prevention. FMEA proactively evaluates risks in processes to mitigate failures before they occur in healthcare.

Unexpected event causing death or serious harm or posing high risk. Sentinel events are critical incidents requiring immediate investigation to prevent future occurrences in healthcare settings.

Plan → Do → Study → Act. The PDSA cycle provides a structured method for testing and refining changes in quality improvement initiatives.

Run chart (or control chart for statistical control). Run charts display data trends over time, helping identify patterns or shifts in quality metrics.

Nonrandom variation from a specific, identifiable factor. Special cause variation indicates anomalies requiring investigation to restore process stability in quality data.

Random, inherent variation within a stable process. Common cause variation reflects normal process fluctuations, addressed through overall system enhancements.

Prioritize key problem categories contributing most to defects/events. Pareto charts apply the 80/20 rule to focus efforts on the most significant issues in quality improvement.

Patient injury resulting from medication use. ADEs encompass any harm from drugs, including allergic reactions or errors, highlighting the need for monitoring.

ADE is harm; medication error is preventable mistake (may or may not harm). ADEs focus on patient harm from medications, whereas errors are preventable deviations regardless of outcome.

System improvement (nonpunitive focus). RCA promotes a systems-based approach to errors, fostering a culture of continuous improvement over punishment.

Error that occurred but did not reach the patient. Near misses provide valuable insights into potential system flaws without causing harm, allowing proactive improvements.

Identify underlying system causes after a serious event to prevent recurrence. RCA systematically uncovers root causes of incidents to implement targeted interventions and enhance safety.